Corteva, Inc. CTVA
Corteva, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.4B | $16.9B | $17.2B | $17.5B | $15.7B | $14.2B | $13.8B | $14.3B |
| R&D expense | $1.5B | $1.4B | $1.3B | $1.2B | $1.2B | $1.1B | $1.1B | $1.4B |
| SG&A expense | $3.5B | $3.2B | $3.2B | $3.2B | $3.2B | $3.0B | $3.1B | $3.0B |
| Income tax | $484.0M | $412.0M | $152.0M | $210.0M | $524.0M | -$81.0M | -$46.0M | -$31.0M |
| Net income | $1.1B | $907.0M | $735.0M | $1.1B | $1.8B | $681.0M | -$959.0M | -$5.1B |
| EPS (diluted) | $1.60 | $1.30 | $1.03 | $1.58 | $2.37 | $0.91 | $-1.28 | $-6.76 |
| Operating cash flow | $3.5B | $2.3B | $1.8B | $912.0M | $2.8B | $2.1B | $1.1B | $483.0M |
| Free cash flow | — | — | — | — | — | — | -$93.0M | -$1.0B |
| Cash & equivalents | $4.5B | $3.1B | $2.6B | $3.2B | $4.5B | $3.5B | $1.8B | $2.3B |
| Inventory | $5.7B | $5.4B | $6.9B | $6.8B | $5.2B | $4.9B | $5.0B | $5.3B |
| Total assets | $42.8B | $40.8B | $43.0B | $42.6B | $42.3B | $42.6B | $42.4B | $108.7B |
| Shareholders' equity | $24.4B | $24.0B | $25.3B | $25.5B | $25.6B | $25.1B | $24.6B | $75.2B |
Growth · year-over-year · Revenue CAGR 2.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.9% | -1.8% | -1.3% | +11.5% | +10.1% | +2.7% | -3.1% | — |
| Net income growth | +20.6% | +23.4% | -35.9% | -34.8% | +158.3% | — | — | — |
| EPS growth | +23.1% | +26.2% | -34.8% | -33.3% | +160.4% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.